However, the fact that a large percentage of women in the breast cancer cohort had at time point one undetectable levels is in concordance with the fact that the expression of VEGF-A165b is downregulated in a large variety of cancers8,10,29,30. This evidence concerns the gene VEGFA and breast carcinoma.